質問 1:MNB is a multinational IT company with headquarters in Asia and with operations in all continents.
MNB is attempting to expand its operations in Europe. This is seen as a major challenge as the European market is very well developed and highly competitive.
MNB develops and manufactures its own products. Parts and assemblies are sourced across Asia, America and Europe. These are sometimes purchased locally as a condition of a contract, but MNB aims to include as much of its own equipment as possible. Transfer prices between MNB's subsidiaries can be set in YEN, USD, EURO, GBP. Transfer prices are revised every month in line with production times as most goods are made on short order with sales cycles running at 3-4 months.
What types of risk are being presented here?
A. Political risk
B. Currency risk
C. Fraud risk
D. Legal risk
E. Environmental risk
F. Economic risk
正解:A,B,F
質問 2:RFG is considering a major expansion that will result in a more diversified business model.
At present, RFG's market capitalisation is $240 million. This is based on a beta of 1.6. The risk free rate is 4% and the market rate of return is 9%. RFG is financed entirely by equity. The company generates an annual cash surplus of $28.8 million.
The expansion will cost $50 million and will generate future cash flows of $12 million in perpetuity. This new business will reduce RFG's beta to 1.4.
Calculate the adjusted present value of the expansion.
A. $321 million
B. $59 million
C. $81 million
D. $131 million
正解:C
質問 3:A patient has been prescribed a new medicine by their physician. The medicine is accompanied by a leaflet describing potential adverse effects associated with taking it. Most of these potentially adverse effects are trivial, but the leaflet states that three patients in every 10,000 who take the medicine suffer a severe reaction requiring urgent medical attention.
Which of the following statements is true?
A. The patient should not be concerned because only those few patients who are susceptible to this reaction are at risk.
B. Statistically, the medicine is safe.
C. Statistical probabilities mean very little in themselves when dealing with decisions that could have serious consequences, such as whether to take this medicine.
D. The patient should ignore the risk because there is only a 0.03% risk of a severe adverse reaction.
正解:C
質問 4:E purchases parts for one of the machines it manufactures from Country X Place the risk classification next to the risk it relates to:
正解:
質問 5:A project has a net present value of $2 million.
Total cash outflows of this project have a present value of $14 million, which includes staff costs of $10 million.
What is the project's sensitivity to staff costs?
A. 20%
B. 63%
C. 14%
D. 71%
正解:A
質問 6:Which of the following statements are true of residual risk?
A. Residual risk is the risk that remains after risk mitigation has taken place.
B. Residual risk may be accepted if management feels the company can bear the risk.
C. Residual risk has to be accepted.
D. Residual risk should never be accepted.
E. If residual risk is too great then the company should not expose itself to the risk situation.
正解:A,B,E
TopExamは君にCIMAPRA19-P03-1の問題集を提供して、あなたの試験への復習にヘルプを提供して、君に難しい専門知識を楽に勉強させます。TopExamは君の試験への合格を期待しています。
弊社のCIMA CIMAPRA19-P03-1を利用すれば試験に合格できます
弊社のCIMA CIMAPRA19-P03-1は専門家たちが長年の経験を通して最新のシラバスに従って研究し出した勉強資料です。弊社はCIMAPRA19-P03-1問題集の質問と答えが間違いないのを保証いたします。
この問題集は過去のデータから分析して作成されて、カバー率が高くて、受験者としてのあなたを助けて時間とお金を節約して試験に合格する通過率を高めます。我々の問題集は的中率が高くて、100%の合格率を保証します。我々の高質量のCIMA CIMAPRA19-P03-1を利用すれば、君は一回で試験に合格できます。
CIMA CIMAPRA19-P03-1 認定試験の出題範囲:
トピック | 出題範囲 |
---|
トピック 1 | - Discuss various issues relating to internal audit in organisations
- Evaluate cyber risk reporting
|
トピック 2 | - Recommend internal controls for risk management
- Analyse Source and Types of Risk
|
トピック 3 | - Revise and practice questions under exam conditions
- Discuss ways of managing Risks
|
トピック 4 | - Explain Governace Risks
- Analyse cyber Threats
- Enterprise Risk
|
参照:https://planner.cimaglobal.com/proqual/2019/strategic/P3
弊社は無料CIMA CIMAPRA19-P03-1サンプルを提供します
お客様は問題集を購入する時、問題集の質量を心配するかもしれませんが、我々はこのことを解決するために、お客様に無料CIMAPRA19-P03-1サンプルを提供いたします。そうすると、お客様は購入する前にサンプルをダウンロードしてやってみることができます。君はこのCIMAPRA19-P03-1問題集は自分に適するかどうか判断して購入を決めることができます。
CIMAPRA19-P03-1試験ツール:あなたの訓練に便利をもたらすために、あなたは自分のペースによって複数のパソコンで設置できます。
安全的な支払方式を利用しています
Credit Cardは今まで全世界の一番安全の支払方式です。少数の手続きの費用かかる必要がありますとはいえ、保障があります。お客様の利益を保障するために、弊社のCIMAPRA19-P03-1問題集は全部Credit Cardで支払われることができます。
領収書について:社名入りの領収書が必要な場合、メールで社名に記入していただき送信してください。弊社はPDF版の領収書を提供いたします。
弊社は失敗したら全額で返金することを承諾します
我々は弊社のCIMAPRA19-P03-1問題集に自信を持っていますから、試験に失敗したら返金する承諾をします。我々のCIMA CIMAPRA19-P03-1を利用して君は試験に合格できると信じています。もし試験に失敗したら、我々は君の支払ったお金を君に全額で返して、君の試験の失敗する経済損失を減少します。
一年間の無料更新サービスを提供します
君が弊社のCIMA CIMAPRA19-P03-1をご購入になってから、我々の承諾する一年間の更新サービスが無料で得られています。弊社の専門家たちは毎日更新状態を検査していますから、この一年間、更新されたら、弊社は更新されたCIMA CIMAPRA19-P03-1をお客様のメールアドレスにお送りいたします。だから、お客様はいつもタイムリーに更新の通知を受けることができます。我々は購入した一年間でお客様がずっと最新版のCIMA CIMAPRA19-P03-1を持っていることを保証します。